openPR Logo
Press release

Hip Implant Manufacturers Target of Congressional Probe

12-26-2011 06:38 AM CET | Politics, Law & Society

Press release from: Nadrich & Cohen LLP

Nadrich & Cohen LLP reports that the federal government is attempting to implement new legislation that would require enhanced safety testing and tracking of hip implant devices.

Los Angeles, CA, December 23, 2011 – In response to growing concerns over the safety and efficacy of metal-on-metal hip implants, members of the U.S. Senate have proposed a new law which would require companies that manufacture these devices to conduct additional safety testing once they are made available to the public.

The new legislation was proposed in an effort to curb the number of lawsuits being filed by consumers who claim they suffered serious injuries after receiving a metal hip replacement device. Johnson & Johnson’s DePuy Orthopedics is currently facing numerous lawsuits from patients who say the company’s ASR and Pinnacle hip implant systems caused serious pain, tissue damage and other complications. Other hip implant manufacturers under fire from angry consumers include Wright Medical Technologies, which produced the now-recalled CONSERVE hip implant system, Biomet, manufacturer of the Magnum hip replacement system and Zimmer, maker of the Durom cup.

The senators who sponsored the bill are hoping that it will allow for greater tracking of the failure rates of these devices. Specifically, the legislation is designed to track those devices which are approved under the U.S. Food and Drug Administration’s 510(k) rule. This system allows for a streamlined approval process in which medical device manufacturers are only required to prove that their product is similar to one already available on the open market. The 510(k) process has been highly criticized in recent years, most notably after the recall of DePuy’s ASR XL Acetabular and ASR Hip Resurfacing Systems in 2010.

As part of their efforts to enhance consumer safety, the senators who proposed the bill also sent letters to five major manufacturers of medical devices, including Zimmer and Johnson & Johnson. The letters included a request for more information about how the safety of hip implants is monitored and how product recalls are handled when they become necessary.

In the case of Johnson & Johnson, the senators wanted to know specifically when the company became aware of problems with its ASR hip implants and how the safety issues were tracked. As of November 2011, the company faced approximately 3,500 lawsuits from plaintiffs alleging serious injury after receiving one of these devices.

If you or a loved one has experienced serious pain, swelling, infection, tissue damage or other negative side effects that you believe were caused by a metal-on-metal hip implant, you need to contact an experienced personal injury attorney to discuss your case. Prominent national law firm Nadrich & Cohen LLP is currently reviewing hip implant claims from patients in all 50 states. No-cost, no-obligation case evaluations are available by calling 1-800-722-0765 or visiting our hip injury resource center at www.DePuyHipReplacementLawyers.net.

Nadrich & Cohen LLP is a national law firm specializing in representing clients nationwide who’ve been injured by defective medical devices, harmful prescription drugs, faulty products, traffic accidents, workplace accidents and dog bites. To learn more about our firm, visit www.PersonalInjuryLawCal.com.

Jennifer Poole
National Client Intake Coordinator
Nadrich & Cohen LLP
12100 Wilshire Blvd.
Suite 1250
Los Angeles, CA 90025
800-718-4658
www.personalinjurylawcal.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hip Implant Manufacturers Target of Congressional Probe here

News-ID: 205333 • Views: 1907

More Releases from Nadrich & Cohen LLP

Yaz Lawsuit Settlements Reach $142 Million
Nadrich & Cohen, LLP reports that Bayer is continuing to offer settlements to plaintiffs involved in federal Yaz side effects litigation. Los Angeles, CA, April 27, 2012 – Nadrich & Cohen, LLP reports that German drug-maker Bayer AG has settled approximately 651 Yaz side effects lawsuits totaling $142 million. Earlier this month, it was reported that the drug-maker had reached settlements in approximately 500 cases filed by women who claimed
Yaz, Yasmin to Get New Labels as FDA Warns of Blood Clot Risk
Nadrich & Cohen, LLP reports that Yaz and similar birth control pills are to receive updated warning labels advising patients of the risk for developing serious blood clots. Los Angeles, CA, April 10, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has ordered Bayer to produce new warning labels for several of its oral contraceptives, including Yaz, Yasmin and Beyaz.
FDA Schedules Advisory Panel Meeting to Discuss Metal Hip Safety
Nadrich & Cohen, LLP reports that the FDA has scheduled an advisory panel to discuss the safety of metal hip implants. Los Angeles, CA, March 29, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has a scheduled an advisory panel meeting to discuss the safety of metal hip implants and all-metal hip resurfacing systems. The two-day panel, which is expected
Pradaxa Side Effects Lawsuits Filed in Federal Court
Nadrich & Cohen, LLP reports that three Pradaxa side effects lawsuits have been filed in federal courts across the country. Los Angeles, CA, March 7, 2012 – National law firm Nadrich & Cohen, LLP has learned that three Pradaxa side effects lawsuits have been filed against Boehringer Ingelheim, the drug’s manufacturer. The cases were filed in federal district courts located in Tennessee, Kentucky and Louisiana and it’s believed they are the

All 5 Releases


More Releases for Johnson

Catheters Market - Evolution Landscape 2025 | Medtronics, Inc., Johnson & Johnso …
Global Catheters Market: Snapshot Catheters are medical tubes that are inserted in the body cavities, vessels, or ducts to remove fluids, perform a surgery, or treat diseases. Whereas, catheters are mostly used for removing fluids by inserting in body cavities, particularly the bladder. These flexible tubes play a very significant role for aged people and patients with medical conditions that impairs the ability to urinate. Connected to the drainage bags, these
Global Erythropoietin Market 2019 - Amgen, Johnson & Johnson, Roche
This new report by Eon Market Research, titled “Global Erythropoietin Market 2019 Research Report, 2015 – 2025” offers a comprehensive analysis of Erythropoietin industry at a global as well as regional and country level. Key facts analyzed in this report include the Erythropoietin market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025. This report primarily focuses on the study of the competitive
Global Steroid-Corticosteroids Market 2018 - GlaxoSmithKline, Pfizer, Johnson an …
Apex Market Reports, recently published a detailed market research study focused on the “Steroid-Corticosteroids Market” across the global, regional and country level. The report provides 360° analysis of “Steroid-Corticosteroids Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Steroid-Corticosteroids on the basis of
Global Precision Medicine Market 2018 - Johnson & Johnson, IBM, GE Healthcare
The statistical surveying information incorporated into the Precision Medicine report is the aftereffect of significant essential and optional research exercises. The report fragments the worldwide market for Precision Medicine based on makers, item compose, applications, and Region. In this report, each fragment is contemplated completely and measurements are introduced in detail. The report offers an exact outline of the worldwide Precision Medicine advertise covering key factors, for example, drivers and
United States Triamcinolone Market Report 2016 : Sanofi, Pfizer, Johnson & Johns …
Qyresearchreports include new market research report "United States Triamcinolone Market Report 2016" to its huge collection of research reports. The research study detailed in the report on the United States Triamcinolone market presents an extensive databank of information that covers all aspects related to the market. Some of these aspects are directly related to the market’s functions. Considering the economic and legal governing factors, the Triamcinolone market is described on the
Global Sunscreen Market 2018-2023 L’Oreal, Kose, Johnson & Johnson
Sunscreen Market Research 2018 A market study "Global Sunscreen Market" examines the performance of the Sunscreen market 2018. It encloses an in-depth Research of the Sunscreen market state and the competitive landscape globally. This report analyzes the potential of Sunscreen market in the present and the future prospects from various angles in detail. The Global Sunscreen Market 2018 report includes Sunscreen market Revenue, market Share, Sunscreen industry volume, market Trends, Sunscreen Growth